PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSIF.L Regulatory News (SSIF)

  • There is currently no data for SSIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

B Share Scheme and Delisting

29 Jun 2023 07:00

RNS Number : 2867E
Secured Income Fund PLC
29 June 2023
 

Secured Income Fund Plc

LEI: 213800TR2S2TT6PKVH57

29 June 2023

SECURED INCOME FUND PLC

(the "Company")

B Share Scheme and Delisting

Pursuant to the authority received from shareholders at the general meeting held on 23 March 2021, the Board has resolved to return £3,159,621 to Shareholders via a seventh Return of Capital by the issue of B Shares.

B Shares of £1 each will be paid up from capital and issued to all Shareholders by way of a bonus issue pro-rata to their holding of Ordinary Shares on the basis of one B Share for approximately every 16.66 Ordinary Shares held at the Record Date of 6.00 p.m. on 6 July 2023. The B Shares will be issued on 7 July 2023 and immediately redeemed at £1 per B Share. The Redemption Date in respect of this Return of Capital is 7 July 2023. The proceeds from the redemption of the B Shares, which is equivalent to 6.0 pence per Ordinary Share, will be sent to uncertificated Shareholders through CREST or via cheque to certificated Shareholders.

Timetable

It is expected that the timetable will be as follows:

Record date of seventh Return of Capital

6.00 p.m. on 6 July 2023

Ex-date in respect of seventh Return of Capital

7 July 2023

Redemption date of seventh Return of Capital

7 July 2023

Dispatch of cheques in respect of certificated holders

14 July 2023

Uncertificated holders credited with cash proceeds

Pay date for B Share return of capital

17 July 2023

17 July 2023

All redemption payments will be paid gross of tax.

Following the issue and redemption of B shares on 7 July 2023, the total number of Ordinary Shares in issue will remain at 52,660,350 and the total number of voting rights in the Company is 52,660,350. There are no shares held in treasury.

The above figure of 52,660,350 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Delisting

At an extra ordinary general meeting held on 16 December 2021, shareholders in the Company voted in favour of the resolution to delist the Company from the Specialist Funds Segment of the London Stock Exchange once the net assets of the Company fell below £7,000,000. This threshold will be crossed on the ex-date for the seventh Return of Capital on 7 July 2023. The Company therefore proposes to delist from the Specialist Fund Segment of the London Stock Exchange effective 4 August 2023.

The principal effects of the delisting are:

1. There will be no public market on any recognised investment exchange or multilateral trading facility for the Ordinary Shares and, consequently, there can be no guarantee that a Shareholder will be able to purchase or sell any Ordinary Shares;

 

2. While the Ordinary Shares will remain freely transferable, it is likely that the liquidity and marketability of the Ordinary Shares will, in the future, be more constrained than at present and the secondary market value of such Ordinary Shares may be adversely affected as a consequence;

 

3. In the absence of a formal market, it may be more difficult for shareholders to determine the market value of their investment in the Company at any given time;

 

4. The corporate governance, regulatory and financial reporting regime which applies to companies whose shares are admitted to trading on the Specialist Fund Segment will no longer apply;

 

5. There may be taxation consequences for Shareholders as a result of the Shares no longer being admitted to trading on the Specialist Fund Segment. Shareholders should consult their own professional advisers and seek their own advice in connection with the potential consequences of the Cancellation of Trading, including any potential changes in the tax treatment of their holding of Shares; and

 

6. Following the Cancellation of Trading, the Company will cease to be treated as an investment trust with effect from the start of the accounting period in which the Cancellation of Trading occurs. The Directors therefore expect that the Company will cease to be treated as an investment trust for the accounting period which begins on 1 July 2023. As a result of no longer being an investment trust the Company will continue to be liable to UK corporation tax on its profits after deducting allowable expenses. Any gain on the realisation of the investment portfolio above its value on the date prior to the Company losing investment trust status will also be subject to UK corporation tax.

 

The Company will remain registered with the Registrar of Companies in England & Wales in accordance with and subject to the Companies Act 2006, notwithstanding the Cancellation. Shareholders should also note that the Takeover Code will continue to apply to the Company following the Cancellation for a period of 10 years from the date of Cancellation.

The Company will also continue to be bound by its Articles of Association (which require shareholder approval for certain matters) following the Cancellation.

 

Shareholders should be aware that if the Cancellation takes effect, they will at that time cease to hold shares in a quoted company and will become Shareholders in an unquoted company which will be likely significantly to reduce the marketability and liquidity of the Ordinary Shares and the principal effects referred to above will automatically apply to the Company from the date of the Cancellation.

The above considerations are not exhaustive, and Shareholders should seek their own independent advice when assessing the likely impact of the Cancellation on them.

Portfolio Update

 

At 31 May 2023, the Company's investment portfolio comprised ten direct loans with a total carrying value of £5.3 million. The legacy loans across the three remaining borrowers are fully impaired under IFRS 9 and therefore have zero carrying value assigned to them.

 

It is anticipated that the completion of the managed wind-down will take approximately 12 to 18 months. The Directors remain focussed on the realisation of the Company's remaining assets pursuant to the Company's objective of delivering investors total proceeds as close to NAV as possible. B share distributions will continue to be made as and when there are sufficient proceeds.

 

For further announcements regarding the delisting, please visit the website http://www.securedincomefundplc.co.uk/delisting, where you will also be able to register for email updates.

 

For further information please contact:

 

Directors

David Stevenson (Chair)

Susan Gaynor Coley

Brett Miller

 

 

 

tel: +44 7973 873785

tel: +44 7977 130673

tel: +44 7770 447338

 

 

finnCap Ltd.

Corporate Finance: William Marle

Sales: Mark Whitfeld

tel: +44 20 7220 0500

 

(http://www.securedincomefundplc.co.uk/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEVLFLXQLEBBK
Date   Source Headline
14th Mar 20179:00 amRNSHalf-year Report
10th Mar 20172:30 pmRNSHolding(s) in Company
10th Mar 20172:30 pmRNSHolding(s) in Company
9th Mar 20179:30 amRNSNet Asset Value(s)
8th Mar 20177:00 amRNSUpdate re. Proposals for the Company's Future
21st Feb 20177:00 amRNSProposals for the Company's Future
15th Feb 20173:00 pmRNSDividend Declaration
7th Feb 20177:00 amRNSMonthly Fact Sheet
6th Feb 20172:30 pmRNSNet Asset Value(s)
12th Jan 201711:00 amRNSDividend Declaration
11th Jan 20175:00 pmRNSMonthly Fact Sheet
10th Jan 20171:30 pmRNSNet Asset Value(s)
14th Dec 20164:00 pmRNSMonthly Fact Sheet - Replacement
14th Dec 20169:00 amRNSMonthly Fact Sheet - Replacement
13th Dec 20162:00 pmRNSMonthly Fact Sheet
12th Dec 20163:14 pmRNSDividend Declaration - Replacement
12th Dec 20169:00 amRNSDividend Declaration
9th Dec 20162:34 pmRNSResult of AGM
9th Dec 201610:00 amRNSNet Asset Value(s)
21st Nov 201610:00 amRNSDividend Declaration
11th Nov 20169:30 amRNSMonthly Fact Sheet
8th Nov 201610:15 amRNSNet Asset Value(s)
7th Nov 201611:32 amRNSFund Manager Share Purchase
25th Oct 20167:00 amRNSDividend Declaration
17th Oct 20167:00 amRNSAnnual Financial Report
12th Oct 201610:15 amRNSMonthly Fact Sheet
10th Oct 20162:05 pmRNSNet Asset Value(s)
3rd Oct 20167:00 amRNSPortfolio Update
21st Sep 201610:00 amRNSDividend Declaration
14th Sep 20161:45 pmRNSMonthly Fact Sheet
9th Sep 20163:33 pmRNSNet Asset Value(s)
6th Sep 20169:48 amRNSUpdate research from QuotedData
1st Sep 20168:00 amRNSChange of Name
1st Sep 20167:00 amRNSChange of Adviser
23rd Aug 20167:00 amRNSDividend Declaration
16th Aug 20169:45 amRNSMonthly Fact Sheet
9th Aug 20167:00 amRNSNet Asset Value(s)
3rd Aug 201611:50 amRNSResult of General Meeting
22nd Jul 20161:00 pmRNSChange of Name
19th Jul 20163:24 pmRNSDirector Resignation
14th Jul 201610:00 amRNSDividend Declaration
13th Jul 20162:30 pmRNSMonthly Fact Sheet
8th Jul 20169:30 amRNSNet Asset Value(s)
7th Jul 20167:00 amRNSNotice of GM
28th Jun 201611:00 amRNSDividend Declaration
21st Jun 20168:06 amRNSDirectorate Change
16th Jun 20168:26 amRNSMonthly Fact Sheet
14th Jun 201610:55 amRNSNet Asset Value(s)
25th May 20167:00 amRNSDividend Declaration
16th May 20164:51 pmRNSMonthly Fact Sheet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.